| RS1828565145 |
NPR2
|
Health Risk |
Likely pathogenic |
Acromesomelic dysplasia 1, Maroteaux type |
| RS1828572665 |
PLEC
|
Health Risk |
Likely pathogenic |
Epidermolysis bullosa simplex 5B, with muscular dystrophy |
| RS1828591 |
HHIP
|
Health Risk |
association |
Chronic obstructive pulmonary disease, biomass related |
| RS1828624396 |
RELN
|
Health Risk |
Likely pathogenic |
Familial temporal lobe epilepsy 7, Familial temporal lobe epilepsy 7 |
| RS1828636794 |
SYK
|
Health Risk |
Pathogenic |
Joint swelling, Skin rash |
| RS1828651198 |
ELP1
|
Health Risk |
Pathogenic |
— |
| RS1828665576 |
GNE
|
Health Risk |
Pathogenic |
GNE myopathy, Sialuria |
| RS182866658 |
NEB
|
Health Risk |
Conflicting classifications of pathogenicity |
Nemaline myopathy 2, NEB-related disorder |
| RS1828669338 |
GNE
|
Health Risk |
Pathogenic/Likely pathogenic |
GNE myopathy, Sialuria |
| RS1828679645 |
EXOSC3
|
Health Risk |
Conflicting classifications of pathogenicity |
Pontocerebellar hypoplasia type 1B, Pontocerebellar hypoplasia type 1B |
| RS1828696455 |
GNE
|
Health Risk |
Likely pathogenic |
Sialuria, GNE myopathy |
| RS1828703342 |
GNE
|
Health Risk |
Likely pathogenic |
GNE myopathy, GNE myopathy |
| RS1828715424 |
IARS1
|
Health Risk |
Pathogenic |
— |
| RS182871847 |
MSH6
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Lynch syndrome 5 |
| RS1828721782 |
VCP
|
Health Risk |
Likely pathogenic |
FRONTOTEMPORAL DEMENTIA WITHOUT AMYOTROPHIC LATERAL SCLEROSIS 6, WITH NEUROFIBRILLARY TANGLES |
| RS1828723159 |
ALG2
|
Health Risk |
Likely pathogenic |
Congenital myasthenic syndrome 14, Congenital myasthenic syndrome 14 |
| RS1828723406 |
VCP
|
Health Risk |
Conflicting classifications of pathogenicity |
Frontotemporal dementia and/or amyotrophic lateral sclerosis 6, Inclusion body myopathy with Paget disease of bone and frontotemporal dementia |
| RS1828729293 |
ALG2
|
Health Risk |
Conflicting classifications of pathogenicity |
Congenital myasthenic syndrome 14, ALG2-congenital disorder of glycosylation |
| RS1828729991 |
ELP1
|
Health Risk |
Likely pathogenic |
Familial dysautonomia, Familial dysautonomia |
| RS182873269 |
CACNA1S
|
Health Risk |
Conflicting classifications of pathogenicity |
Hypokalemic periodic paralysis, type 1 |
| RS1828741490 |
XPA
|
Health Risk |
Pathogenic |
Xeroderma pigmentosum group A, Xeroderma pigmentosum group A |
| RS1828745258 |
XPA
|
Health Risk |
Pathogenic |
— |
| RS182875134 |
IL10RB
|
Health Risk |
Conflicting classifications of pathogenicity |
Inflammatory bowel disease 25, IL10RB-related disorder |
| RS1828756507 |
VCP
|
Health Risk |
Conflicting classifications of pathogenicity |
Inclusion body myopathy with Paget disease of bone and frontotemporal dementia type 1, Frontotemporal dementia and/or amyotrophic lateral sclerosis 6 |
| RS1828760353 |
TRPM6
|
Health Risk |
Pathogenic |
Intestinal hypomagnesemia 1, Intestinal hypomagnesemia 1 |
| RS1828783140 |
VCP
|
Health Risk |
Likely pathogenic |
Frontotemporal dementia and/or amyotrophic lateral sclerosis 6, Inclusion body myopathy with Paget disease of bone and frontotemporal dementia |
| RS1828784075 |
VCP
|
Health Risk |
Likely pathogenic |
Frontotemporal dementia and/or amyotrophic lateral sclerosis 6, Inclusion body myopathy with Paget disease of bone and frontotemporal dementia |
| RS1828785763 |
TMC1
|
Health Risk |
Likely pathogenic |
Hearing loss, autosomal recessive |
| RS1828800296 |
ELP1
|
Health Risk |
Conflicting classifications of pathogenicity |
Medulloblastoma, Familial dysautonomia |
| RS1828806280 |
ALG2
|
Health Risk |
Likely pathogenic |
ALG2-congenital disorder of glycosylation, ALG2-congenital disorder of glycosylation |
| RS1828806340 |
ALG2
|
Health Risk |
Pathogenic |
Congenital myasthenic syndrome 14, Congenital myasthenic syndrome 14 |
| RS1828818571 |
XPA
|
Health Risk |
Pathogenic |
Xeroderma pigmentosum group A, Xeroderma pigmentosum group A |
| RS1828864269 |
VCP
|
Health Risk |
Likely pathogenic |
Inclusion body myopathy with Paget disease of bone and frontotemporal dementia type 1, Inclusion body myopathy with Paget disease of bone and frontotemporal dementia type 1 |
| RS1828864557 |
TMC1
|
Health Risk |
Likely pathogenic |
Autosomal recessive nonsyndromic hearing loss 7, Autosomal recessive nonsyndromic hearing loss 7 |
| RS1828865320 |
VCP
|
Health Risk |
Conflicting classifications of pathogenicity |
Frontotemporal dementia and/or amyotrophic lateral sclerosis 6, Inclusion body myopathy with Paget disease of bone and frontotemporal dementia |
| RS1828866977 |
ELP1
|
Health Risk |
Pathogenic |
— |
| RS182887871 |
FRAS1
|
Health Risk |
Conflicting classifications of pathogenicity |
Fraser syndrome 1, Fraser syndrome 1 |
| RS1828901917 |
COL27A1
|
Health Risk |
Likely pathogenic |
— |
| RS1828910974 |
GNE
|
Health Risk |
Conflicting classifications of pathogenicity |
GNE myopathy, Sialuria |
| RS1828914261 |
GNE
|
Health Risk |
Likely pathogenic |
GNE myopathy, GNE myopathy |
| RS1828921198 |
GNE
|
Health Risk |
Likely pathogenic |
GNE myopathy, GNE myopathy |
| RS1828923734 |
IFT74
|
Health Risk |
Pathogenic |
— |
| RS1828929851 |
GNE
|
Health Risk |
Likely pathogenic |
GNE myopathy, GNE myopathy |
| RS1828930645 |
GNE
|
Health Risk |
Likely pathogenic |
GNE myopathy, Sialuria |
| RS182893847 |
PRKN
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS182894280 |
ACAN
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1828949796 |
NANS
|
Health Risk |
Pathogenic |
Spondyloepimetaphyseal dysplasia, Genevieve type |
| RS1828965654 |
TMC1
|
Health Risk |
Likely pathogenic |
Hearing loss, autosomal recessive |
| RS1829025291 |
GNE
|
Health Risk |
Pathogenic |
GNE myopathy, Sialuria |
| RS1829026390 |
GNE
|
Health Risk |
Pathogenic |
Sialuria, GNE myopathy |
| RS1829027066 |
GNE
|
Health Risk |
Likely pathogenic |
GNE myopathy, GNE myopathy |
| RS1829035889 |
FANCG
|
Health Risk |
Pathogenic |
Fanconi anemia complementation group G, Fanconi anemia complementation group G |
| RS1829040508 |
FANCG
|
Health Risk |
Pathogenic |
Fanconi anemia complementation group G, Fanconi anemia complementation group G |
| RS1829041127 |
FANCG
|
Health Risk |
Pathogenic/Likely pathogenic |
Fanconi anemia complementation group G, Fanconi anemia |
| RS1829042768 |
FANCG
|
Health Risk |
Pathogenic |
Fanconi anemia complementation group G, Fanconi anemia complementation group G |
| RS1829045299 |
AGTPBP1
|
Health Risk |
Likely pathogenic |
Neurodegeneration, childhood-onset |
| RS1829054259 |
FANCG
|
Health Risk |
Likely pathogenic |
Fanconi anemia, Fanconi anemia |
| RS1829054352 |
FANCG
|
Health Risk |
Likely pathogenic |
Fanconi anemia complementation group G, Fanconi anemia |
| RS1829055917 |
FANCG
|
Health Risk |
Pathogenic |
Fanconi anemia complementation group G, Fanconi anemia complementation group G |
| RS1829055945 |
FANCG
|
Health Risk |
Pathogenic |
Fanconi anemia complementation group G, Fanconi anemia complementation group G |
| RS1829056657 |
FANCG
|
Health Risk |
Likely pathogenic |
Fanconi anemia complementation group G, Fanconi anemia complementation group G |
| RS1829062032 |
FANCG
|
Health Risk |
Likely pathogenic |
Fanconi anemia, Fanconi anemia |
| RS1829062071 |
FANCG
|
Health Risk |
Likely pathogenic |
Fanconi anemia, Fanconi anemia complementation group G |
| RS1829064231 |
COL27A1
|
Health Risk |
Likely pathogenic |
Steel syndrome, Steel syndrome |
| RS1829065047 |
FANCG
|
Health Risk |
Likely pathogenic |
Fanconi anemia, Fanconi anemia |
| RS1829066243 |
FANCG
|
Health Risk |
Likely pathogenic |
Fanconi anemia complementation group G, Fanconi anemia complementation group G |
| RS1829066424 |
FANCG
|
Health Risk |
Pathogenic |
Fanconi anemia, Fanconi anemia |
| RS1829068323 |
FANCG
|
Health Risk |
Pathogenic |
Fanconi anemia, Fanconi anemia |
| RS1829075705 |
FANCG
|
Health Risk |
Conflicting classifications of pathogenicity |
Fanconi anemia, Inborn genetic diseases |
| RS1829085768 |
FANCG
|
Health Risk |
Likely pathogenic |
Fanconi anemia complementation group G, Fanconi anemia complementation group G |
| RS1829086026 |
FANCG
|
Health Risk |
Pathogenic |
Fanconi anemia complementation group G, Fanconi anemia |
| RS1829091761 |
FANCG
|
Health Risk |
Likely pathogenic |
Fanconi anemia, Fanconi anemia |
| RS1829091954 |
FANCG
|
Health Risk |
Pathogenic |
Fanconi anemia complementation group G, Fanconi anemia complementation group G |
| RS1829092043 |
FANCG
|
Health Risk |
Pathogenic/Likely pathogenic |
Fanconi anemia, Fanconi anemia complementation group G |
| RS1829092348 |
COL27A1
|
Health Risk |
Likely pathogenic |
— |
| RS1829092483 |
FANCG
|
Health Risk |
Pathogenic |
Fanconi anemia complementation group G, Fanconi anemia |
| RS1829096099 |
ENG
|
Health Risk |
Pathogenic |
Telangiectasia, hereditary hemorrhagic |
| RS1829096531 |
ENG
|
Health Risk |
Pathogenic |
Telangiectasia, hereditary hemorrhagic |
| RS1829103511 |
FANCG
|
Health Risk |
Pathogenic/Likely pathogenic |
Fanconi anemia complementation group G, Fanconi anemia |
| RS1829103547 |
FANCG
|
Health Risk |
Pathogenic |
Fanconi anemia, Fanconi anemia |
| RS1829104194 |
FANCG
|
Health Risk |
Pathogenic |
Fanconi anemia complementation group G, Fanconi anemia |
| RS1829123346 |
FANCG
|
Health Risk |
Pathogenic |
Fanconi anemia, Fanconi anemia |
| RS1829128546 |
FANCG
|
Health Risk |
Pathogenic |
Fanconi anemia complementation group G, Fanconi anemia complementation group G |
| RS1829129603 |
FANCG
|
Health Risk |
Likely pathogenic |
Fanconi anemia complementation group G, Pituitary stalk interruption syndrome |
| RS1829129696 |
FANCG
|
Health Risk |
Pathogenic |
Fanconi anemia complementation group G, Fanconi anemia complementation group G |
| RS1829130135 |
FANCG
|
Health Risk |
Pathogenic/Likely pathogenic |
Fanconi anemia complementation group G, Fanconi anemia |
| RS1829130643 |
FANCG
|
Health Risk |
Pathogenic |
Fanconi anemia complementation group G, Fanconi anemia |
| RS182913453 |
ETFDH
|
Health Risk |
Likely pathogenic |
Multiple acyl-CoA dehydrogenase deficiency, Multiple acyl-CoA dehydrogenase deficiency |
| RS1829144030 |
FANCG
|
Health Risk |
Likely pathogenic |
Fanconi anemia, Fanconi anemia |
| RS1829144428 |
FANCG
|
Health Risk |
Pathogenic |
Fanconi anemia complementation group G, Fanconi anemia complementation group G |
| RS1829145397 |
FANCG
|
Health Risk |
Likely pathogenic |
Fanconi anemia complementation group G, Fanconi anemia complementation group G |
| RS182914589 |
TRIP11
|
Health Risk |
Conflicting classifications of pathogenicity |
Achondrogenesis, type IA |
| RS1829161980 |
COL27A1
|
Health Risk |
Likely pathogenic |
— |
| RS1829177357 |
FKTN
|
Health Risk |
Conflicting classifications of pathogenicity |
Walker-Warburg congenital muscular dystrophy, Cardiovascular phenotype |
| RS1829181339 |
FKTN
|
Health Risk |
Likely pathogenic |
Dilated cardiomyopathy 1X, Dilated cardiomyopathy 1X |
| RS1829190548 |
FKTN
|
Health Risk |
Conflicting classifications of pathogenicity |
Dilated cardiomyopathy 1X, Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies) |
| RS182919150 |
HNF4A
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial hyperinsulinism, Maturity-onset diabetes of the young type 1 |
| RS182923857 |
BCKDHA
|
Health Risk |
Conflicting classifications of pathogenicity |
Maple syrup urine disease, Maple syrup urine disease type 1A |
| RS1829252908 |
TJP2
|
Health Risk |
Likely pathogenic |
— |
| RS1829255885 |
TJP2
|
Health Risk |
Conflicting classifications of pathogenicity |
— |